HIV-1 entry inhibitors: new targets, novel therapies.
Pierson
Theodore C
TC
Department of Microbiology, University of Pennsylvania, 225 Johnson Pavilion, Philadelphia, PA 19104, USA.
Doms
Robert W
RW
D000818:Animals; D019380:Anti-HIV Agents / Q000494:pharmacology*; D015815:Cell Adhesion Molecules / Q000187:drug effects / Q000378:metabolism; D015195:Drug Design; D015686:Gene Products, env / Q000037:antagonists & inhibitors* / Q000187:drug effects* / Q000378:metabolism; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1 / Q000472:pathogenicity; D006801:Humans; D037181:Lectins, C-Type / Q000187:drug effects / Q000378:metabolism; D019718:Receptors, CXCR4; D011956:Receptors, Cell Surface / Q000187:drug effects / Q000378:metabolism; D019707:Receptors, Chemokine; D000099215:DC-Specific ICAM-3 Grabbing Nonintegrin
D019380:Anti-HIV Agents; D015815:Cell Adhesion Molecules; D015686:Gene Products, env; D037181:Lectins, C-Type; D019718:Receptors, CXCR4; D011956:Receptors, Cell Surface; D019707:Receptors, Chemokine; D000099215:DC-Specific ICAM-3 Grabbing Nonintegrin